The U.S. Food and Drug Administration has approved AbbVie's Vyalev (foscarbidopa and foslevodopa) for adults living with ...
HealthDay on MSN18h
FDA Approves Vyalev for Advanced Parkinson DiseaseThe U.S. Food and Drug Administration has approved Vyalev (foscarbidopa and foslevodopa) for adults living with advanced ...
15h
Neurologist Jason Aldred helped conduct trials for the device in Spokane through his work at Selkirk Neurology, where he ...
Plus: Groupon cofounder’s healthcare venture, investments in CAR-T therapies and the upcoming Forbes Healthcare Summit.
AbbVie should report strong Q3 2024 results next week and increase the full-year guidance. Explore more details here.
United Statescategory Phoenix officers put on leave in probe of violent arrest of disabled Black man 1:36 AM UTC Businesscategory US fines American Airlines record $50 million over treatment of ...
Fast bowler Rosemary Mair and offspinner Leigh Kasperek are out from the squad that won them their maiden T20 World Cup ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback